Cargando…
Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positiv...
Autores principales: | Farkas, Henriette, Levy, Donald, Supina, Dylan, Berger, Melvin, Prusty, Subhransu, Fridman, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254637/ https://www.ncbi.nlm.nih.gov/pubmed/32514273 http://dx.doi.org/10.1186/s13223-020-00439-9 |
Ejemplares similares
-
Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
por: Farkas, Henriette, et al.
Publicado: (2019) -
The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews
por: Jean-Baptiste, Milenka, et al.
Publicado: (2022) -
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
por: Reshef, Avner, et al.
Publicado: (2019) -
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021) -
Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review
por: Levy, Donald, et al.
Publicado: (2020)